Namwiwat Medical Corporation PCL (BKK:NAM)
Thailand flag Thailand · Delayed Price · Currency is THB
4.200
+0.080 (1.94%)
At close: Aug 15, 2025, 4:30 PM ICT

BKK:NAM Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,6151,1141,1011,099995.36676.61
Other Revenue
1.531.962.320.99-2.22
1,6171,1161,1031,100995.36678.84
Revenue Growth (YoY)
72.60%1.20%0.25%10.55%46.63%-
Cost of Revenue
1,056646.51620.7772.91654.73467.39
Gross Profit
560.74469.84482.38327.45340.63211.45
Selling, General & Admin
315.08255.54230.16103.39115.1865.31
Operating Expenses
315.08255.54230.16103.39115.1865.31
Operating Income
245.66214.29252.22224.06225.45146.14
Interest Expense
-20.34-12.68-15.73-12.99-14.03-12.46
Interest & Investment Income
12.8815.641.571.060.020.02
Earnings From Equity Investments
----0.55-0.27-11.4
Currency Exchange Gain (Loss)
9.469.46-13.041.14-
Other Non Operating Income (Expenses)
7.815.11.65-8.14--
EBT Excluding Unusual Items
255.47231.8239.71216.48212.3122.3
Gain (Loss) on Sale of Investments
-----10.65
Gain (Loss) on Sale of Assets
0.140.1410.575.441.48-
Pretax Income
255.61231.94250.28221.91213.78132.95
Income Tax Expense
52.6249.1249.5346.244.122.51
Earnings From Continuing Operations
202.99182.83200.75175.71169.68110.44
Minority Interest in Earnings
-22.98-1.96--4.971.39
Net Income
180.01180.87200.75175.71174.65111.83
Net Income to Common
180.01180.87200.75175.71174.65111.83
Net Income Growth
11.11%-9.90%14.25%0.61%56.17%-
Shares Outstanding (Basic)
700700615262020
Shares Outstanding (Diluted)
700700615262020
Shares Change (YoY)
4.94%13.90%2237.63%31.45%--
EPS (Basic)
0.260.260.336.688.735.59
EPS (Diluted)
0.260.260.336.688.735.59
EPS Growth
5.88%-20.90%-95.11%-23.46%56.17%-
Free Cash Flow
5.15-42.62228.27-81.1693.61104.71
Free Cash Flow Per Share
0.01-0.060.37-3.094.685.24
Dividend Per Share
0.1500.1500.090---
Dividend Growth
66.67%66.67%----
Gross Margin
34.69%42.09%43.73%29.76%34.22%31.15%
Operating Margin
15.20%19.20%22.86%20.36%22.65%21.53%
Profit Margin
11.13%16.20%18.20%15.97%17.55%16.47%
Free Cash Flow Margin
0.32%-3.82%20.69%-7.38%9.40%15.43%
EBITDA
276.81240.24277.45241.25239.88-
EBITDA Margin
17.12%21.52%25.15%21.93%24.10%-
D&A For EBITDA
31.1525.9425.2317.1914.43-
EBIT
245.66214.29252.22224.06225.45146.14
EBIT Margin
15.20%19.20%22.86%20.36%22.65%21.53%
Effective Tax Rate
20.59%21.18%19.79%20.82%20.63%16.93%
Revenue as Reported
1,6341,1311,1151,111997.98678.84
Source: S&P Global Market Intelligence. Standard template. Financial Sources.